Category Archives: Newsletters

Blue Horseshoe Stocks: SPY Calls & More

Posted on by

SPDR S&P500 ETF (SPY)

We are wrapping up a very solid week, which even included a twenty-bagger (NFLX $300 Calls, +2069%). This morning, with the markets appearing to be geared toward  bullish finish to the week, we will entertain a range of SPY Calls, for the possibility of some good daytrades to really end things on a high note going into the upcoming long weekend.

The SPY is our go-to target when not a lot else is jumping off of the scanner, and we’ve played it successfully on more occasions to count. The most recent being a couple of sets of ideas we made just prior to the New Year, which resulted in gains ranging from 300-600%

Today, we are going to be tracking the SPY Weekly $263.50-265 Calls.*
_______

Bonus Ideas:
JBHT 02/15 $100 & $105 Calls
CGC Weekly $43-44.50 Calls*
_______

*Please do not attempt to trade weekly options on a Friday unless you an advanced level trader with disposable funds.

Extended Watchlist:
BPTH, MTNB, KNDI, HSGX, CRBP, CCCL

EXCLUSIVE Interview with new COO of PASO

Posted on by

Patient Access Solutions, Inc. PASO

We’ve been focusing upon PASO this week, beginning on Monday with our PASO Special Report on the company that we suggest you read before proceeding any further!

As mentioned in that report, PASO recently issued a PR naming Dr. Donald Chiappetta the new Chief Operating Officer, in charge of day-to-day operations as well as the company’s long-term strategy moving forward. We also mentioned that we’d have the honor of speaking with Dr. Chiappetta this week, and that time has come.

We are very excited to present the EXCLUSIVE interview that we conducted Patient Access Solutions brand new executive, and learn more about this rapidly growing company straight from the source!

STT Interviews Dr. Donald Chiappetta, COO, Patient Access Solutions Inc. (PASO)

CLICK HERE or on the graphic above to listen now!

We would strongly suggest that you subscribe to our YouTube channel so you don’t miss out on any future executive interviews conducted on our Stock Traders Talk website!

Extended Watchlist:
MBOT, GMNX, RBZ, CRZO, TMDI,

Blue Horseshoe Stocks: NFLX Review & More

Posted on by

Netflix, Inc. NFLX – Review

Nearly as often as we signal weekly options ideas, we also formulate longer term ones. Last month on the 12th, we entered our interest in the NFLX 01/25 $290-300 Calls into the log, and after an epic start to 2019, we’ve seen some really great moves.

NFLX stock alone, subsequent to our last alert, has traded for as little as 231.23 up to as high as yesterday’s new top mark of 357.22. That’s an incredible 54% jump in less than five weeks! What that move allowed our selected contracts to do has been nothing short of Earth-shattering.

$290 Calls – Range: 3.80-68.25 – Max Gain: 1696%
$292.50 Calls – Range: 3.28-49.22 – Max Gain: 1400%
$295 Calls – Range: 3.80-60.45 – Max Gain: 1491%
$297.50 Calls – Range: 3.47-59.76 – Max Gain: 1622%
$300 Calls – Range: 2.66-57.69 – Max Gain: 2069%
______

Fresh Options Ideas:
UAL Weekly $85-86 Calls
GT 03/01 $19-20 Calls

We also want to remind our readers to check out our PASO Report from Monday if you missed that, and stay tuned because we’ve got an exclusive interview with the company’s new Chief Operating Officer coming your way very soon!

Extended Watchlist:
PASO, HIPH, LXRX, GERN, TBLT, SCHW, TYME

Blue Horseshoe Stocks: TLRY Recap & More

Posted on by


Tilray, Inc. TLRY

Our first order of business this morning is to just provide a quick recap of our successful options idea from Friday, which we did not provide yesterday due to the release of our Special Report on PASO.(Check that report out if you missed it)

In Friday’s newsletter, we submitted the TLRY Weekly $92.50-95 Calls as potential day-trade candidates, and every single contract in that range provided huge multi-bag gain opportunities!

$92.50 Calls – Range: 2.10-8.30 – Max Gain: 295%
$93 Calls – Range: 2.00-9.20 – Max Gain: 360%
$93.50 Calls – Range: 1.80-5.00 – Max Gain: 178%
$94 Calls – Range: 2.14-9.83 – Max Gain: 359%
$95 Calls – Range: 1.21-8.85 – Max Gain: 631%

OPKO Health, Inc. OPK – Review

The last time we signaled OPK for observation was just a few weeks ago, on December 28th, just as the stock was gapping up off of its annual lows. Following that report, we’ve seen a couple weeks of steady gains, in an overall range from 2.84-3.935. That represents a solid 39% increase, and a good start to the 2019 calendar year.

We’ve also observed CEO Phillip Frost purchasing 15,000 shares out of the open market yesterday, near those highs. The next step for OPK would be to make a run at its 200DMA of 4.12, so we’ll continue to keep it on our radar in the days and weeks ahead.

Extended Watchlist:
PASO, DTEA, FTNW, KTOV, CVM

Blue Horseshoe Stocks: PASO Special Report

Posted on by

Patient Access Solutions, Inc. PASO – Special Report

We’re beginning this fresh trading week with a special report on a stock you’re not going to want to overlook. PASO (PASHealth) operates in the healthcare industry, for which it has adapted a wide array of services to provide solutions in a rapidly changing healthcare environment.

We are focusing upon PASO at an critical time in the company’s development, having only just announced an important step in a series of acquisitions that fall in line with its overall strategy of opening integrated health centers across New York State and in other regions of the country. Just last week, it was announced that the company had acquired a multi-specialty health and wellness facility.

It is the private practice of Dr. Donald Chiappetta in West Babylon, NY, a town on Long Island just a short drive from the company’s other facilities in Plainview NY.  The practice has been in operation for over two decades, and produces annual revenue exceeding $1.5M in serving, on average, more than 2000 patients on a monthly basis.

On the new union forged here in the new year, Dr. Chiappetta commented: “My staff and I are excited to join the Company. Integrating our practice and specialties with the Plainview facility will create a full service offering and offer our patients the ability to access our team of professionals across a larger geographic area.” (>>View Full PR)

Dr. Chiappetta has also been named Chief Operating Officer of PASO, responsible for managing day-to-day operations as well as facilitating growth both organically and through further strategic acquisitions. In addition to his private practice, he has also worked for both NFL, and Olympic athletes.

We are pleased to report that we will be conducting an exclusive interview with Dr. Chiappetta later this week via our Stock Traders Talk channel, so be sure you’re subscribed to our daily newsletter and keep an eye out for that announcement! In the meantime, take a look at why we’re interested in PASO from a technical standpoint on the chart snapshot below.


The recent bullish rise of PASO is sure to have raised some eyebrows, with considerably increased volume over the same time span.  The next key area of resistance for the stock to contend with sits at .0391. We’ll be looking for the PASO to test that area in the days and weeks ahead.
____

FRESH NEWS:
Just hitting the wires this morning is another update to the PASO newsreel.

COMMACK, NY, Jan. 14, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Patient Access Solutions, Inc. (OTC PINK: PASO), a provider of technology and management solutions for the healthcare industry is proud to announce Dr. James Lederer will be joining the Company as the Director of Behavioral Health for the Group. Dr. Lederer will be based at the Plainview, NY Integrated Health facility. (>>View Full PR)
_____

For More Information on PASO Please Visit:
PASHEALTH.COM